IRIS
AVENOSO, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 689
Totale 689
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 689
Totale 689
Salva come PNG Salva come JPEG
Città #
Genova 376
Genoa 163
Rapallo 78
Vado Ligure 69
Bordighera 3
Totale 689
Salva come PNG Salva come JPEG
Nome #
Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide 132
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question". 120
Hepatosplenic T-cell lymphoma with aberrant expression of serum β-HCG: A case report 86
VALUTAZIONE D’ESPRESSIONE DI MICRO-RNA IN PAZIENTI AFFETTI DA MIELODISPLASIA. UN POSSIBILE STRUMENTO UTILE PER LA COMPRESIONE DELLA PATOGENESI E DEI MECCANISMI DI PROGRESSIONE DI MALATTIA 83
Haploientical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography 81
Case report – Prolonged SARS-CoV-2 positive PCR after resolution of symptoms 34
Next Generation Sequencing and Microrna Assay in a Cohort of Patients Affected By Myelodysplastic Syndromes. an Analysis of Clinical and Genotypic Features 31
Lymphoid blast crisis after prolonged treatment‐free remission in chronic myeloid leukaemia after tyrosine kinase inhibitor de‐escalation during the COVID‐19 pandemic 15
Systematic screening and focused evaluation for venous occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatment 13
SARS-CoV-2 infection in aplastic anemia 12
Unusual CD34 positivity in acute myeloid leukaemia with myelodysplasia‐related changes with megakaryoblastic differentiation 11
Post-transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA-mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT 10
Thymoma and pure red cell aplasia with hypoplasia of megakaryocytopoiesis: A rare and life-treating condition 9
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation 8
Early and late-onset veno-occlusive disease/sinusoidal syndrome post allogeneic stem cell transplantation - a real-world UK experience 8
Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience 8
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party 8
CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy 7
ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party 7
Myeloablative dose of busulfan and fludarabine combined with in vivo T-cell depletion is a safe and effective conditioning for acute myeloid leukaemia and myelodysplastic syndrome patients 6
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients 6
Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure Lymphoma 6
Systematic screening and focused evaluation for veno-occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatment 6
A Cellular Therapy with Haploidentical Peripheral Hematopoietic Stem Cell Transplantation MAY be a Therapeutic Option in Patients with Relapsed Lymphoma with Chemorefractory Disease 4
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease 4
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy 4
Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study 4
Thymoma and pure red cell aplasia with hypoplasia of megakaryocytopoiesis: A rare and life-treating condition 3
Microbial Contamination of Haematopoietic Stem Cell Products: A Single Centre Experience 3
Human parainfluenza virus type 3 infections in a haemato-oncology unit: social distancing measures needed in outpatient clinics 3
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT 2
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT 2
Modern views of nutritional support in patients undergoing allogeneic stem cell transplantation 2
Second allogeneic haematopoietic stem cell transplant conditioned with treosulfan and fludarabine is associated with encouraging overall survival and transplant related mortality in late relapse of myeloid malignancies 2
Totale 740
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.909
article - articoli 3.661
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.570
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020156 0 0 0 19 21 20 22 14 18 17 15 10
2020/202171 12 4 7 0 10 3 6 5 8 5 5 6
2021/202298 5 7 4 8 3 14 4 20 11 9 1 12
2022/2023103 8 6 0 5 13 13 2 3 23 1 27 2
2023/2024168 3 6 2 27 14 20 2 43 11 17 4 19
2024/202576 12 47 12 5 0 0 0 0 0 0 0 0
Totale 740